No Data
Tibet Cheezheng Tibetan Medicine (002287.SZ) disclosed a special dividend plan proposing a distribution of 2.2 yuan for every 10 shares.
Tibet Cheezheng Tibetan Medicine (002287.SZ) disclosed a special dividend plan, and the company intends to distribute Cash / Money Market of 1... for every 10 shares to all shareholders.
Tibet Cheezheng Tibetan Medicine (002287.SZ): It has advantageous products suitable for the investment market in various treatment areas, including the respiratory and digestive systems.
On November 15, Gelonghui reported that Tibet Cheezheng Tibetan Medicine (002287.SZ) stated during a specific entity research on November 14, 2024, that the company holds 141 pharmaceutical approval numbers, with products covering multiple Tibetan medicine specialty treatment areas such as orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, digestive, and cardiovascular fields. The招商 can explore and activate more quality products from the company, injecting new vitality into these products through precise market development strategies. The company has developed detailed招商 plans tailored to the different characteristics of various products. The company has suitable treatments in multiple fields including the respiratory and digestive systems.
Qizheng Tibetan Medicine: Report for the third quarter of 2024
tibet cheezheng tibetan medicine (002287.SZ) net income in the first three quarters was 0.393 billion yuan, a year-on-year increase of 3.38%.
Gelonghui October 29th | tibet cheezheng tibetan medicine (002287.SZ) released the third quarter report for 2024. The company achieved revenue of 1.472 billion yuan in the first three quarters, an 18.10% year-on-year increase; net income of 0.393 billion yuan, a 3.38% year-on-year increase. In the third quarter alone, revenue reached 0.462 billion yuan, up 10.92% year-on-year; net income was 67.6902 million yuan, down 0.80% year-on-year.
Tibet Cheezheng Tibetan Medicine (002287.SZ): Plans to launch an employee stock ownership plan in 2024.
Gelonghui September 26th | Tibet Cheezheng Tibetan Medicine (002287.SZ) announced the 2024 employee stock holding plan, the source of funds for this employee stock holding plan is the company's provision of long-term incentive fund, legal employee compensation, self-raised funds, or other ways permitted by laws and regulations. The total amount of funds for this employee stock holding plan does not exceed 156 million yuan, of which the company's provision of long-term incentive fund does not exceed 144 million yuan. The company does not provide any form of financial assistance such as advances, guarantees, loans to the holders. The employee stock holding plan is denominated in "shares", with each share priced at 1.00 yuan, employees
Tibet Cheezheng Tibetan Medicine: Summary of Half-Year Report in 2024.
